Request Your FREE Special Report Today:
"Top 10 Forever Stocks for Creating Wealth"

 





(privacy policy)

Request your FREE Special Report today and you'll
also receive a complimentary 6-month subscription
to our Daily Profit investment newsletter.

Savient Pharmaceuticals extends clinical trial for treatment-failure gout by one year or more. Shares tank 57%.

Wyatt Research Staff
October 27, 2008
 print 

See (SVNT).
permalink